Hospital Josep Trueta is a public Hospital in the City of Girona in Catalonia. It was opened on 13 April 1956 in honour of the Catalan Surgeon Dr Josep Trueta. The hospital has several departments but most notably an Emergency department, an ICU with almost 100 beds and its own Oncology wing.

During the past decade, Hospital Universitari de Girona Doctor Josep Trueta conducted 116 clinical trials. In the 10-year time frame, 116 clinical trials started and 27 clinical trials were completed, i.e. on average, 23.3% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 17 clinical trials were completed. i.e. 44.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitari de Girona Doctor Josep Trueta" #1 sponsor was "Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta" with 10 trials, followed by "Celgene" with 9 trials sponsored, "Hospital Universitari Vall d'Hebron Research Institute" with 8 trials sponsored, "Pfizer" with 8 trials sponsored and "Boehringer Ingelheim" with 8 trials sponsored. Other sponsors include 139 different institutions and companies that sponsored additional 101 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari de Girona Doctor Josep Trueta" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta" with 3 trials as a collaborator, "Instituto de Salud Carlos III" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 107 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari de Girona Doctor Josep Trueta" are "Ulcerative Colitis" (10 trials), "Crohn Disease" (8 trials), "Multiple Myeloma" (7 trials), "Crohn's Disease" (6 trials) and "Acute Ischemic Stroke" (5 trials). Many other conditions were trialed in "Hospital Universitari de Girona Doctor Josep Trueta" in a lesser frequency.

Most popular intervention types in "Hospital Universitari de Girona Doctor Josep Trueta" are "Drug" (110 trials), "Other" (30 trials), "Biological" (22 trials), "Procedure" (17 trials) and "Device" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Dexamethasone" (8 trials), "Prednisone" (7 trials), "Ozanimod" (4 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari de Girona Doctor Josep Trueta" are 172 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitari de Girona Doctor Josep Trueta". 2 are not yet recruiting, 35 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Hospital Universitari de Girona Doctor Josep Trueta, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari de Girona Doctor Josep Trueta, 6 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 21 trials that are defined as “Not Applicable".

Hospital Universitari de Girona Doctor Josep Trueta has several departments that took part in Clinical trials: "Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica" - 3 trials, "Hospital Universitari de Girona Dr. Josep Trueta; Servicio de Neurologia" - 3 trials